Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 930,000 | 913,000 | 978,000 | 976,000 | 963,000 |
| Cost of Goods | 750,000 | 752,000 | 799,000 | 801,000 | 782,000 |
| Gross Profit | 180,000 | 161,000 | 179,000 | 175,000 | 181,000 |
| Operating Expenses | 180,000 | 173,000 | 165,000 | 169,000 | 167,000 |
| Operating Income | N/A | -12,000 | 14,000 | 6,000 | 14,000 |
| Interest Expense | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 |
| Other Income | 0 | -1,000 | -2,000 | -1,000 | 0 |
| Pre-tax Income | -8,000 | -21,000 | 4,000 | -3,000 | 6,000 |
| Income Tax | -1,000 | -6,000 | N/A | -2,000 | 3,000 |
| Net Income Continuous | -7,000 | -15,000 | 2,000 | -1,000 | 3,000 |
| Net Income | $-7,000 | $-15,000 | $2,000 | $-1,000 | $3,000 |
| EPS Basic Total Ops | -0.06 | -0.13 | 0.01 | -0.01 | 0.03 |
| EPS Basic Continuous Ops | -0.06 | -0.13 | 0.02 | -0.01 | 0.03 |
| EPS Diluted Total Ops | -0.06 | -0.13 | 0.01 | -0.01 | 0.03 |
| EPS Diluted Continuous Ops | -0.06 | -0.13 | 0.02 | -0.01 | 0.03 |
| EPS Diluted Before Non-Recurring Items | 0.03 | -0.03 | 0.06 | N/A | N/A |
| EBITDA(a) | $17,000 | $4,000 | $29,000 | $22,000 | $32,000 |